Allen Hu, Annexon (F), Apellis (F), Apellis (C), Ionis (F), IVERIC Bio (F), Luminthera (F), Roche (F), Roche (C), Stealth Biotherapeutics (F), Stealth Biotherapeutics (C);
Daniel Esmaili, Regeneron (C);
Ramiro Ribiero, Apellis (E);
Caleb Bliss, Apellis (E), Apellis (I);
Daniel Jones, Apellis (E), Apellis (I);
David Brown, Adverum (F), Adverum (C), Allergan (F), Allergan (C), Bayer (F), Bayer (C), Boehringer Ingelheim (C), Boehringer Ingelheim (F), Chengdu Kanghong Biotechnology (F), Clearside Biomedical (F), Genentech/Roche (F), Genentech/Roche (C), Heidelberg (F), Kodiak (F), Lineage (F), Novartis (F), Novartis (C), Ocular Therapetix (C), Optos (F), Optos (C), Regeneron (F), Regeneron (C), Senju (F), Stealth (F), Stealth (C)